BBAGF OTC
BB Biotech AG
1W: +0.0%
1M: +31.8%
3M: +0.0%
YTD: +0.0%
1Y: +3.9%
3Y: +14.9%
$64.36
+3.18 (+5.20%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$305M
+39.5% ▲
5Y CAGR: +7.2%
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
$305M
+39.5% ▲
5Y CAGR: +7.2%
Dividends Paid
$110M
+29.8% ▲
Buybacks
$3M
+0.0% ▲
Net Change in Cash
-$43K
+97.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $691M | -$405M | -$358M | -$207M | $0 |
| Depreciation & Amort. | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $0 | $0 | $0 | $0 | $0 |
| Other Non-Cash Items | -$429M | $310M | $589M | $425M | $305M |
| Operating Cash Flow | $262M | -$95M | $231M | $218M | $305M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | -$87M | $292M | $0 | -$58M | -$187M |
| Stock Repurchased | -$8M | -$9M | -$27M | $0 | -$3M |
| Dividends Paid | -$188M | -$199M | -$212M | -$156M | -$110M |
| Other Financing | -$863K | -$986K | $6M | -$6M | -$5M |
| Financing Cash Flow | -$284M | $92M | -$233M | -$220M | -$305M |
| Net Change in Cash | -$24M | -$4M | -$887K | -$1M | -$43K |
| Cash End of Period | $7M | $3M | $2M | $501K | $458K |
| Free Cash Flow | $262M | -$95M | $231M | $218M | $305M |